跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 28,938 条关于
“IP Group Australia”
全部
28,938
临床试验
18,374
药物
647
机构
991
资讯
8,926
10个月前
RAGE Biotech Raises A$29 Million Series A to Advance RNA Therapeutics for Chronic Inflammatory Diseases
2个月前
Anixa Biosciences Wins Australian Patent Acceptance for Breast Cancer Vaccine, Expanding Global IP Estate
去年
Garden Launches BLOOM AI Engine to Accelerate IP-Aware Drug Discovery
上个月
Pilatus Biosciences Secures U.S. Patent Allowance and Worldwide IP Rights for CD36-Targeted Cancer Therapy PLT012
上个月
Squires Erases PTAB Ax Of Dermatology IP Upheld At ITC
去年
Brazil's Patent Landscape Transformation: Supreme Court Ruling Reshapes Pharmaceutical IP Strategy
去年
Immunophotonics Completes Phase 1b/2a Trial of IP-001 Immunotherapy for Advanced Solid Tumors
2年前
Pharmacosmos Group Acquires G1 Therapeutics for $405 Million to Expand COSELA Access for Cancer Patients
去年
Enanta Pharmaceuticals Challenges Pfizer's Paxlovid in European Patent Court, Seeking Damages for Antiviral IP Infringement
9个月前
PTAB Pendulum Swings Back as Patent Enforcement Landscape Shifts Toward Stronger IP Protection
第 1 页,共 893 页
上一页
下一页